| [1] |
Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome[J]. Ann Rheum Dis, 2018, 77(6): 808-818.
doi: 10.1136/annrheumdis-2018-213225
pmid: 29625968
|
| [2] |
Bettiol A, Hatemi G, Vannozzi L, et al. Treating the different phenotypes of Behçet’s syndrome[J]. Front Immunol, 2019, 10: 2830.
doi: 10.3389/fimmu.2019.02830
URL
|
| [3] |
邹峻, 陈永, 曲环汝, 等. 中国白塞综合征中西医结合诊疗专家共识(2020年)[J]. 老年医学与保健, 2021, 27(1): 14-20.
|
| [4] |
Hou CC, Ye JF, Ma HF, et al. Clinical characteristics and risk factors of intestinal involvement in Behçet’s syndrome patients: a cross-sectional study from a single center[J]. Orphanet J Rare Dis, 2021, 16(1): 132.
doi: 10.1186/s13023-021-01772-x
URL
|
| [5] |
Chen Y, Cai JF, Lin CH, et al. Demography of vascular Behçet’s disease with different gender and age: an investigation with 166 Chinese patients[J]. Orphanet J Rare Dis, 2019, 14(1): 88.
doi: 10.1186/s13023-019-1061-1
URL
|
| [6] |
鲍华芳, 蔡剑飞, 陈永, 等. STAT3磷酸化与白塞病临床活动性的关系[J]. 复旦学报(医学版), 2018, 45(2):169-176.
|
| [7] |
Shen Y, Ma HF, Luo D, et al. High incidence of gastrointestinal ulceration and cytogenetic aberration of trisomy 8 as typical features of Behçet’s disease associated with myelodysplastic syndrome[J]. Biomed Res Int, 2018, 2018: 8535091.
|
| [8] |
Zou J, Luo JF, Shen Y, et al. Cluster analysis of phenotypes of patients with Behçet’s syndrome: a large cohort study from a referral center in China[J]. Arthritis Res Ther, 2021, 23(1): 45.
doi: 10.1186/s13075-021-02429-7
URL
|
| [9] |
McHugh J. Different phenotypes identified for Behçet syndrome[J]. Nat Rev Rheumatol, 2021, 17(4): 188.
|
| [10] |
Zou J, Luo JF, Shen Y, et al. Distinct clinical characteristics of pediatric Behçet’s syndrome: a study from a referral center in China[J]. Mod Rheumatol, 2021, 31(6): 31(6):1158-1163.
doi: 10.1080/14397595.2021.1891670
URL
|
| [11] |
Zou J, Luo D, Shen Y, et al. Characteristics and phenotype heterogeneity in late-onset Behçet’s syndrome: a cohort from a referral center in China[J]. Clin Rheumatol, 2021, 40(6): 2319-2326.
doi: 10.1007/s10067-020-05536-z
URL
|
| [12] |
Ye JF, Hou CC, Bao HF, et al. New insight into the features of Behçet’s disease with gastrointestinal ulcer[J]. Orphanet J Rare Dis, 2021, 16(1): 444.
doi: 10.1186/s13023-021-02056-0
URL
|
| [13] |
Ye JF, Guan JL. Differentiation between intestinal Behçet’s disease and Crohn’s disease based on endoscopy[J]. Turk J Med Sci, 2019, 49(1): 42-49.
doi: 10.3906/sag-1807-67
URL
|
| [14] |
Zhang L, Tian Y, Ye JF, et al. Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet’s disease in the Shanghai Adamantiades-Behçet’s disease database[J]. Orphanet J Rare Dis, 2019, 14(1): 274.
doi: 10.1186/s13023-019-1228-9
URL
|
| [15] |
Bao HF, Hou CC, Ye B, et al. Predictors of infliximab refractory intestinal Behçet’s syndrome: a retrospective cohort study from the Shanghai Behçet’s syndrome database[J]. Mod Rheumatol, 2021. [Epub ahead of print].
|
| [16] |
Hou CC, Ma HF, Ye JF, et al. Plasma exosomes derived from patients with intestinal Behçet’s syndrome induce intestinal epithelial cell pyroptosis[J]. Clin Rheumatol, 2021, 40(10):4143-4155.
doi: 10.1007/s10067-021-05755-y
URL
|
| [17] |
Hou CC, Bao HF, Shen Y, et al. Expression of miRNAs derived from plasma exosomes in patients with intestinal Behçet’s syndrome[J]. Clin Exp Rheumatol, 2021. [Epub ahead of print].
|
| [18] |
Zou J, Lin CH, Wang Y, et al. Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’[J]. Ann Rheum Dis, 2021. [Epub ahead of print].
|
| [19] |
管剑龙,主编. 白塞病新概念[M]. 上海: 复旦大学出版社, 2021:55-91.
|
